Top Markets
#1 Purr Purr +55.52%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +49.56%
#4 Non-Playable Coin Non-Playable Coin +29.16%
#5 StonkBroker StonkBroker +28.75%
#6 ApeX ApeX +27.06%
#7 Kinetiq Kinetiq +24.33%
#8 Pudgy Penguins Pudgy Penguins +21.56%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +21.07%
#10 OriginTrail OriginTrail +20.87%
Coin of the day
Purr Purr
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
ArcticZymes Technologies ASA ArcticZymes Technologies ASA

ArcticZymes Technologies ASA

AZT
Classement en actions #21263
ArcticZymes Technologies ASA is a leading life sciences firm dedicated to the... ArcticZymes Technologies ASA is a leading life sciences firm dedicated to the development, production, and global sale of recombinant enzymes. These specialized enzymes are essential for a variety of applications, including molecular research, in vitro diagnostic testing, and processes within biomanufacturing. The company's diverse product lineup includes several key enzymatic solutions. For example, its salt active nuclease is instrumental in eliminating nucleic acids during the manufacturing of viral vectors, recombinant proteins, and other critical reagents. ArcticZymes also supplies shrimp alkaline phosphatase and accompanying kits, which are vital for purifying samples before both Sanger and next-generation sequencing. Another significant product is cod UNG, frequently utilized in viral and other molecular diagnostic assays, alongside double-strand specific DNases and their related kits, engineered for the efficient removal of double-stranded DNA. The firm's polymerases are designed to drive technological progress in life science, molecular diagnostics, NGS, and synthetic biology. Furthermore, it offers proteinase for applications in microbiological diagnostics and liquid biopsies, and ligases, which are crucial for connecting DNA and RNA fragments. ArcticZymes Technologies boasts a broad international presence, serving markets in Norway, Germany, Lithuania, Italy, various other European nations, the United States, and additional global territories. Founded in 1990, the enterprise was initially known as Biotec Pharmacon ASA until June 2020, when it officially rebranded to its current name. Its corporate headquarters are located in Tromsø, Norway.
Prix de l'action
$2.18
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$111.34M
Changement (1 jour)
-4.15%
Changement (1 an)
-25.43%
Pays
NO
Échange ArcticZymes Technologies ASA (AZT)

Catégorie

Healthcare
Ratio P/B pour ArcticZymes Technologies ASA (AZT)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de ArcticZymes Technologies ASA, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour ArcticZymes Technologies ASA de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH